Clin Osteol 2008; 13(1): 4-7

Quantitative and qualitative parameters of the male skeleton in relation to hormonal homeostasisReview articles

I. Žofková

Keywords: mužský skelet, androgeny, estrogeny, somatotropin-IGF-I, vitamín D, kostní denzita, fraktury v SUMMARY

Published: June 11, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žofková I. Quantitative and qualitative parameters of the male skeleton in relation to hormonal homeostasis. Osteologický bulletin. 2008;13(1):4-7.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wells JC: Sexual dimorphism of body composition. Best Pract Res Clin Endocri­ nol Metab 2006;21:415-430. Go to original source...
    2. Ebeling PR: Idiopathic or hypogonadal osteoporosis in men: current and future treatment options. Treat Endocrinol 2004;3:381-391. Go to original source...
    3. Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata ARM, Carani C. Osteopo­ rosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur J Endocrinol 2006;154:175-185. Go to original source...
    4. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA Mortality after all major types of osteoporotic fracture in men and women: an observational stu­ dy. Lancet 1999;353:878-882. Go to original source...
    5. Compston J. Secondary causes of osteoporosis in men. Calcif Tissue Int 2001;69:193-195. Go to original source...
    6. Štěpán JJ, Lachman M, Zvěřina J, f^covský V, Bayling DJ: Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remode­ ling. J Clin Endocrinol Metab 1989;69:523-527. Go to original source...
    7. Legrand E, Audran M, Guggenbuhl P, Levasseur R, Chales G, Baslé MF, Chappard D. Trabecular bone microarchitecture is related to the number of risk factors and etiology in osteoporotic men. Microsc Res Tech 2007; Jul 27 [Epub ahead of print]. Go to original source...
    8. Lunenfeld B, Nieschlag E. Testosterone therapy in the aging male. Aging Male 2007;10:139-153. Go to original source...
    9. Trancredi A, Reginster JY, Luyckx F, Legros JJ. No major month to month varia­ tion in free testosterone levels in aging males. Minor impact on the biological di­ agnosis of 'andropause'. Psychoneuroendocrinology 2005;30:638-646. Go to original source...
    10. Araujo AB, Esce GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007, Aug 14 [Roub ahead of print]. Go to original source...
    11. Stanley HL, Schmidt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurence of a minimal trauma hip fracture in elderly men? J Am Geriatrics Soc 1991;39:766-771. Go to original source...
    12. Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992;304:4-8. Go to original source...
    13. Mellstrom D, Johnell O, Ljunggren O, Ericsson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C. Free testosterone is an in­ dependent predictor ofBMD and prevalent fractures in elderly men: J Bone Miner Res 2006;2:529-535. Go to original source...
    14. Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ, Chappl CL. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporosis Int 1999;9:91-97. Go to original source...
    15. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Tailor BC, Cauley JA, Orwoll ES. Association of testosterone and estradiol deficiency with osteoporosis and ra­ pid bone loss in older men. J Clin Endocrinol Metab 2006;91:3908-3915. Go to original source...
    16. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Re­ lative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men- J Clin Invest 2000;106:1556-1560. Go to original source...
    17. Välimäki VV, Alfthan H, Ivaska KK, Loyttyniemi E, Pettersson K, Stenman UH, Välimäki MJ. Serum estradiol, testosterone, and sex hormone-binding globulin as regulators ofpeak bone mass and bone turnover rate on young Finnish men. J Clin Endocrinol Metab 2004; 89:3785-3789. Go to original source...
    18. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 2003;88:204-210. Go to original source...
    19. Khosla S, Melton LJ 3rd, Riggs BL. Estrogens and bone health in men. Calcif. Tis­ sue Int 2001;69:189-192. Go to original source...
    20. Matsumoto C, Inada M, Miyaura C. Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone 2006;38:220-226. Go to original source...
    21. Jones MEE, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006;17:53-62. Go to original source...
    22. Lorentzon M, Swanson C, Ericsson AL, Mellstrom D, Ohlsson C. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study. J Bone Miner Res 2006;21:332-339. Go to original source...
    23. Smith MR. Therapy insight: osteoporosis during hormone therapy for prostate cancer. Nat Clin Pract Urol 2005;2:608-615. Go to original source...
    24. Broulík P, Broulíková K: Raloxifen prevents bone loss in castrated male mice. Physiol Res 2007;56:443^47. Go to original source...
    25. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561-570. Go to original source...
    26. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N. Aromatase in human bone tissue. J Bone Miner Res 1997;12:1416-1423. Go to original source...
    27. Vanderchueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocrine Rev 2004;25:389-425. Go to original source...
    28. Välimäki VV, Piippo K, Välimäki S, Loyttyniemi E, Kontula K, Välimäki MJ. The relation ofthe XbaI and PvuII polymorphisms ofthe estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. Osteoporosis Int 2005;16:1633-1640. Go to original source...
    29. Legrand E, Hedde C, Gallois Y, Degasne I, Boux de Casson F, Mathieu E, Baslé MF, Chappard D, Audran M. Osteoporosis in men: a potential role for sex hor­ mone binding globulin. Bone 2001;29:90-95. Go to original source...
    30. Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B. Sex hor­ mone-binding globulin, estradiol, and bone turnover markers in male osteoporo­ sis. Bone 2004;34:933-939. Go to original source...
    31. Ericsson AL, Lorentzon M, Mellstrom D, Vandenput L, Swanson C, Anderson N, Hammond GL, Jakobsson J, Rane A, Orwoll ES, Ljunggren O, Johnall O, Labrie F, Windahl SH, Ohlsson C. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab 2006;91: 5029-5037. Go to original source...
    32. Lombardi G, Tauchmanova L, Di Somma C, Musela T, Rota F, Savanelli MC, Colao A Somatopause: dismetabolic and bone effects. J Endocrinol Invest 2005;28:36-42.
    33. Patel MB, Arden NK, Masterson LM, Phillips DI, Swaminathan R, Syddall HE, Byrne CD, Wood PJ, Cooper C, Holt RI, Hertfordshire Cohort Study Group. Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). Bone 2005;37: 833-841. Go to original source...
    34. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sexhormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000;53:689-695. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.